Literature DB >> 18528306

Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.

Takuma Nomiya1, Kenji Nemoto, Hitoshi Wada, Yoshihiro Takai, Shogo Yamada.   

Abstract

OBJECTIVE/HYPOTHESIS: The purpose of this study is to determine the prognostic factors for local control and significance of total radiation dose in T1 glottic cancer. STUDY
DESIGN: Retrospective study.
METHODS: Data from 163 patients with T1 N0 M0 Stage I glottic squamous cell carcinoma (T1a: 115, T1b: 48) who were treated with radiotherapy alone during 1976 to 2002 were analyzed retrospectively. Age, source, total dose, field size, overall treatment time, and average fraction size were set as variables in multivariate analysis.
RESULTS: The 5-year local control rates (LCR) were 92.3% and 85.0% for patients with T1a and T1b glottic carcinoma, respectively. Only total radiation dose (P = .048) was a significant prognostic factor for local control in multivariate analysis of T1b glottic carcinoma. Local control in the higher total dose group was better than that in the lower total dose group (5 year LCRs were 100% and 76% for the group of > 66 Gy and the group of < or = 66 Gy, respectively. P = .024, logrank test). None of the treatment parameters were shown to be significant prognostic factors in multivariate analysis of T1a glottic carcinoma.
CONCLUSIONS: Radiotherapy with a total dose of 67 to 70 Gy seemed to be required for local control in T1b glottic carcinoma. No significant benefit of total radiation dose > 64 Gy was shown in the analysis of T1a glottic carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 18528306     DOI: 10.1097/MLG.0b013e3181781791

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

Review 1.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

2.  Transoral laser microsurgery for T1b glottic cancer: review of 51 cases.

Authors:  Bernhard G Weiss; Friedrich Ihler; Yiannis Pilavakis; Hendrik A Wolff; Martin Canis; Christian Welz; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-27       Impact factor: 2.503

3.  Usefulness of Semi-cylindrical Beam Spoiler in Treatment of Early Glottic Cancer Using 6 MV Photon Beam.

Authors:  Seong Soo Shin; Sohyun Ahn; Seung-Hyup Baek; Jungwon Kwak; Jin Sung Kim; Woo Sang Ahn
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

4.  Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma?

Authors:  Vera Mahler; Morten Boysen; Kjell Brøndbo
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-08       Impact factor: 2.503

5.  Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.

Authors:  J Cacicedo; F Casquero; O del Hoyo; A Gomez-Iturriaga; L Martinez-Indart; J L Lopez; P Bilbao
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

6.  Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.

Authors:  Mohammad K Khan; Shlomo A Koyfman; Grant K Hunter; Chandana A Reddy; Jerrold P Saxton
Journal:  Radiat Oncol       Date:  2012-11-19       Impact factor: 3.481

7.  Multi-institutional analysis of early glottic cancer from 2000 to 2005.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shinji Naganawa; Shunichi Ishihara; Kazunori Suzuki; Kazuyuki Koyama; Takayuki Murao; Akiko Asano; Yoshihito Nomoto; Yoshimi Horikawa; Masahiro Sasaoka; Yasunori Obata
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

8.  Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer.

Authors:  Yukihisa Tamaki; Yoko Hieda; Rika Yoshida; Takeshi Yoshizako; Takafumi Fuchiwaki; Noriaki Aoi; Kazumasa Sekihara; Kazuhiro Kitajima; Hideyuki Kawauchi; Hajime Kitagaki; Ryohei Sasaki; Taisuke Inomata
Journal:  Nagoya J Med Sci       Date:  2015-11       Impact factor: 1.131

Review 9.  Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

10.  Prognostic factors of patients with initially diagnosed T1a glottic cancer: Novel nomograms and a propensity-score matched cohort analysis.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Hong-Bing Liu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.